Year None202120202019201820172016 Date Latest Press Release June 10, 2019 Eiger Appoints Industry Veteran and Regulatory Affairs Expert Mark Mannebach, PhD, RPh as Vice President of Global Regulatory Affairs June 5, 2019 Eiger Appoints Jeysen Yogaratnam, MB.BCh, BAO, MRCSEd, PhD, MBA, Vice President of Global HDV Clinical Development May 30, 2019 Eiger BioPharmaceuticals to Present at Jefferies 2019 Global Healthcare Conference May 17, 2019 Eiger BioPharmaceuticals Announces Transition of Chief Operating Officer and Executive Medical Officer May 9, 2019 Eiger BioPharmaceuticals Reports First Quarter 2019 Financial Results and Provides Business Update April 30, 2019 Eiger to Present at ChinaBio® Partnering Forum 2019 April 17, 2019 Eiger BioPharmaceuticals Announces Pricing of Public Offering of Common Stock April 17, 2019 Eiger BioPharmaceuticals Announces Proposed Public Offering of Common Stock April 15, 2019 Eiger BioPharmaceuticals Appoints Market Access, Public Policy Expert, and Biotech Veteran Amit K. Sachdev to Board of Directors April 11, 2019 Eiger Announces 36% Durable Virologic Response at 24 Weeks Post-Treatment with Peginterferon Lambda in Phase 2 LIMT HDV Study at The International Liver Congress™ 2019 Pagination First page « first Previous page ‹ previous Page 1 Page 2 Page 3 Page 4 Current page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last »
